Literature DB >> 3120659

[HLA A-B and DR in dilated myocardiopathies].

M Komajda1, C Raffoux, E Salame, J Colombani, Y Grosgogeat, C Cabrol, J Dausset.   

Abstract

HLA A, B typing was performed in 90 patients (90 men, 10 women), and HLA DR typing in 49 patients with dilated cardiomyopathy in order to test the hypothesis that a particular genetic background may influence the immune response in that disease. No significant difference in phenotype frequency of the HLA A and B antigens was observed between patients and control population. In contrast, the HLA DR4 antigen was significantly more frequent among patients (40.8% vs 23.8%, p corrected less than 0.001). The results suggest that genetic factors play a role in the pathogenesis of dilated cardiomyopathy, and that since DR4 is frequently associated with auto-immune manifestations, a modified immune response is possible in dilated cardiomyopathy.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3120659

Source DB:  PubMed          Journal:  Arch Mal Coeur Vaiss        ISSN: 0003-9683


  3 in total

1.  A meta-analysis of HLA-DR polymorphism and genetic susceptibility to idiopathic dilated cardiomyopathy.

Authors:  Bo Jin; Xin-Ping Luo; Huan-Chun Ni; Wei Shen; Hai-Ming Shi; Yong Li
Journal:  Mol Biol Rep       Date:  2011-05-10       Impact factor: 2.316

2.  Do specific HLA antigens predispose to ischaemic heart disease or idiopathic dilated cardiomyopathy?

Authors:  S C Grant; S Sheldon; P A Dyer; R D Levy; N H Brooks
Journal:  Br Heart J       Date:  1994-01

Review 3.  HLA-DR3 antigen in the resistance to idiopathic dilated cardiomyopathy.

Authors:  B Jin; B W Wu; Z C Wen; H M Shi; J Zhu
Journal:  Braz J Med Biol Res       Date:  2016-03-18       Impact factor: 2.590

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.